Back to top

rating-upgrade: Archive

Zacks Equity Research

Mercantile Bank (MBWM) Upgraded to Buy: Here's What You Should Know

Mercantile Bank (MBWM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

MBWMPositive Net Change

Zacks Equity Research

Community Financial (CBU) Upgraded to Strong Buy: Here's Why

Community Financial (CBU) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

CBUPositive Net Change

Zacks Equity Research

CanFite Biopharma (CANF) Upgraded to Strong Buy: Here's What You Should Know

CanFite Biopharma (CANF) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

CANFPositive Net Change

Zacks Equity Research

All You Need to Know About Kopin (KOPN) Rating Upgrade to Strong Buy

Kopin (KOPN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

KOPNNegative Net Change

Zacks Equity Research

AAR (AIR) Upgraded to Buy: Here's What You Should Know

AAR (AIR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

AIRNegative Net Change

Zacks Equity Research

All You Need to Know About Alto Neuroscience, Inc. (ANRO) Rating Upgrade to Buy

Alto Neuroscience, Inc. (ANRO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ANRONegative Net Change

Zacks Equity Research

Amneal (AMRX) Upgraded to Strong Buy: Here's Why

Amneal (AMRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

AMRXNegative Net Change

Zacks Equity Research

Royal Gold (RGLD) Upgraded to Buy: What Does It Mean for the Stock?

Royal Gold (RGLD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

RGLDNegative Net Change

Zacks Equity Research

Charles Schwab (SCHW) Upgraded to Buy: What Does It Mean for the Stock?

Charles Schwab (SCHW) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

SCHWNegative Net Change

Zacks Equity Research

Amazon (AMZN) Upgraded to Strong Buy: Here's Why

Amazon (AMZN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

AMZNPositive Net Change

Zacks Equity Research

Brookfield Infrastructure (BIP) Upgraded to Buy: What Does It Mean for the Stock?

Brookfield Infrastructure (BIP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

BIPPositive Net Change

Zacks Equity Research

All You Need to Know About Cogent (CCOI) Rating Upgrade to Buy

Cogent (CCOI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

CCOIPositive Net Change

Zacks Equity Research

What Makes Trevi Therapeutics (TRVI) a New Buy Stock

Trevi Therapeutics (TRVI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

TRVIPositive Net Change

Zacks Equity Research

US Foods (USFD) Upgraded to Buy: Here's What You Should Know

US Foods (USFD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

USFDNegative Net Change

Zacks Equity Research

All You Need to Know About PepGen (PEPG) Rating Upgrade to Buy

PepGen (PEPG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

PEPGNegative Net Change

Zacks Equity Research

Immatics (IMTX) Upgraded to Buy: What Does It Mean for the Stock?

Immatics (IMTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

IMTXPositive Net Change

Zacks Equity Research

All You Need to Know About CytomX Therapeutics (CTMX) Rating Upgrade to Strong Buy

CytomX Therapeutics (CTMX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

CTMXPositive Net Change

Zacks Equity Research

All You Need to Know About BWX (BWXT) Rating Upgrade to Buy

BWX (BWXT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

BWXTNegative Net Change

Zacks Equity Research

Q32 Bio (QTTB) Upgraded to Buy: What Does It Mean for the Stock?

Q32 Bio (QTTB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

QTTBNegative Net Change

Zacks Equity Research

Fresenius (FMS) Upgraded to Strong Buy: Here's What You Should Know

Fresenius (FMS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

FMSNegative Net Change

Zacks Equity Research

All You Need to Know About Allot Communications (ALLT) Rating Upgrade to Strong Buy

Allot Communications (ALLT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

ALLTNegative Net Change

Zacks Equity Research

Trupanion (TRUP) Upgraded to Strong Buy: Here's Why

Trupanion (TRUP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

TRUPNegative Net Change

Zacks Equity Research

What Makes NewtekOne (NEWT) a New Buy Stock

NewtekOne (NEWT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

NEWTPositive Net Change

Zacks Equity Research

Deckers (DECK) Upgraded to Strong Buy: What Does It Mean for the Stock?

Deckers (DECK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

DECKPositive Net Change

Zacks Equity Research

All You Need to Know About Spartacus Acquisition (NN) Rating Upgrade to Strong Buy

Spartacus Acquisition (NN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

NNPositive Net Change